← FDA DRUG APPROVALS

FDA ANDA · ANDA088337

ERGOSTAT

Sponsor: WATSON LABS INC

APPLICATION
ANDA088337
TYPE
ANDA
LATEST ACTION
1991-06-14
ROUTE
SUBLINGUAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ERGOSTATDiscontinued
ERGOTAMINE TARTRATE 2MG · TABLET · SUBLINGUAL

Approval history

1991-06-14Manufacturing (CMC) · Supplement 12AP
1989-01-19Manufacturing (CMC) · Supplement 8AP
1989-01-19Manufacturing (CMC) · Supplement 9AP
1988-09-26Labeling · Supplement 10AP
1987-07-09Manufacturing (CMC) · Supplement 4AP
1987-07-09Manufacturing (CMC) · Supplement 3AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →